A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT02123758 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02123758
- Sponsor
- Aragon Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-09
- Primary completion
- 2016-06-27
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.